Exome Asset Management as of Dec. 31, 2025
Portfolio Holdings for Exome Asset Management
Exome Asset Management holds 60 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Praxis Precision Medicines I Com New (PRAX) | 8.2 | $17M | 58k | 294.74 | |
| Cogent Biosciences (COGT) | 5.2 | $11M | 306k | 35.52 | |
| Guardant Health (GH) | 4.8 | $10M | 98k | 102.14 | |
| Ionis Pharmaceuticals (IONS) | 4.4 | $9.2M | 117k | 79.11 | |
| Eli Lilly & Co. (LLY) | 4.0 | $8.4M | 7.9k | 1074.68 | |
| Cytokinetics Com New (CYTK) | 3.8 | $7.9M | 125k | 63.54 | |
| Wave Life Sciences SHS (WVE) | 3.4 | $7.2M | 422k | 17.00 | |
| Vera Therapeutics Cl A (VERA) | 3.0 | $6.3M | 124k | 50.64 | |
| Bridgebio Pharma (BBIO) | 3.0 | $6.2M | 81k | 76.49 | |
| Anthem (ELV) | 2.9 | $6.0M | 17k | 350.55 | |
| Astrazeneca Sponsored Adr | 2.5 | $5.3M | 28k | 185.48 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.2 | $4.5M | 27k | 170.00 | |
| Natera (NTRA) | 2.0 | $4.3M | 19k | 229.09 | |
| Immunovant (IMVT) | 1.9 | $4.0M | 159k | 25.42 | |
| Universal Hlth Svcs CL B (UHS) | 1.8 | $3.8M | 18k | 218.02 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $3.7M | 7.7k | 487.25 | |
| Agios Pharmaceuticals (AGIO) | 1.8 | $3.7M | 137k | 27.22 | |
| Disc Medicine (IRON) | 1.8 | $3.7M | 47k | 79.41 | |
| Intuitive Surgical Com New (ISRG) | 1.7 | $3.6M | 6.4k | 566.36 | |
| Glaukos (GKOS) | 1.7 | $3.6M | 32k | 112.91 | |
| Enliven Therapeutics (ELVN) | 1.6 | $3.4M | 222k | 15.40 | |
| Celcuity (CELC) | 1.6 | $3.4M | 34k | 99.74 | |
| Apellis Pharmaceuticals (APLS) | 1.6 | $3.4M | 136k | 25.12 | |
| Travere Therapeutics (TVTX) | 1.6 | $3.4M | 89k | 38.21 | |
| Dex (DXCM) | 1.6 | $3.3M | 50k | 66.37 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.6 | $3.3M | 50k | 66.39 | |
| Cytomx Therapeutics (CTMX) | 1.5 | $3.2M | 745k | 4.26 | |
| Liquidia Corporation Com New (LQDA) | 1.5 | $3.1M | 91k | 34.49 | |
| Verastem Com New (VSTM) | 1.5 | $3.1M | 402k | 7.72 | |
| Travere Therapeutics Put Put Option | 1.4 | $2.9M | 75k | 38.21 | |
| Alumis (ALMS) | 1.4 | $2.9M | 292k | 9.76 | |
| Penumbra (PEN) | 1.3 | $2.8M | 9.0k | 310.91 | |
| 10x Genomics Cl A Com (TXG) | 1.3 | $2.7M | 164k | 16.31 | |
| Immunocore Hldgs Ads (IMCR) | 1.3 | $2.7M | 77k | 34.71 | |
| Edgewise Therapeutics (EWTX) | 1.2 | $2.5M | 100k | 24.82 | |
| Nextcure Com New (NXTC) | 1.1 | $2.3M | 165k | 14.19 | |
| Belite Bio Sponsored Ads (BLTE) | 1.1 | $2.3M | 14k | 159.96 | |
| Waystar Holding Corp (WAY) | 1.1 | $2.3M | 69k | 32.75 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 1.0 | $2.2M | 649k | 3.37 | |
| Karyopharm Therapeutics Com New (KPTI) | 1.0 | $2.2M | 296k | 7.36 | |
| Adagene Ads (ADAG) | 1.0 | $2.0M | 1.1M | 1.89 | |
| Novabridge Biosciences Sponsored Ads (NBP) | 1.0 | $2.0M | 500k | 3.98 | |
| UnitedHealth (UNH) | 0.9 | $1.9M | 5.8k | 330.11 | |
| Palisade Bio (PALI) | 0.9 | $1.8M | 758k | 2.35 | |
| Upstream Bio (UPB) | 0.8 | $1.8M | 65k | 27.15 | |
| Gossamer Bio (GOSS) | 0.7 | $1.4M | 452k | 3.10 | |
| Disc Medicine Put Put Option | 0.6 | $1.3M | 16k | 79.41 | |
| Inhibikase Therapeutics Com New (IKT) | 0.6 | $1.2M | 600k | 2.05 | |
| Iqvia Holdings (IQV) | 0.6 | $1.2M | 5.4k | 225.41 | |
| Tenet Healthcare Corp Com New (THC) | 0.6 | $1.2M | 6.1k | 198.72 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.5 | $1.1M | 140k | 8.14 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $1.0M | 92k | 11.31 | |
| Establishment Labs Holdings Ord (ESTA) | 0.5 | $955k | 13k | 72.88 | |
| Ultragenyx Pharmaceutical In Put Call Option | 0.4 | $810k | 35k | 23.00 | |
| Alumis Put Put Option | 0.2 | $519k | 53k | 9.76 | |
| Aldeyra Therapeutics Call Call Option | 0.2 | $518k | 100k | 5.18 | |
| Rapt Therapeutics Com New (RAPT) | 0.2 | $481k | 14k | 33.87 | |
| Precigen Put Put Option | 0.2 | $418k | 100k | 4.18 | |
| Arbutus Biopharma (ABUS) | 0.2 | $363k | 76k | 4.81 | |
| Soleno Therapeutics Put Put Option | 0.2 | $328k | 7.1k | 46.13 |
